Guoer D. Ma
Zhenjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Diagnostic value of pentraxin 3 in plasma and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients: a prospective multicenter clinical study.
Journal: Emerging microbes & infections
Published: April 29, 2026
Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis.
Journal: Microbiology spectrum
Published: September 09, 2025
Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: a multicenter cohort study.
Journal: Microbiology spectrum
Published: May 22, 2025
Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients.
Journal: Microbiology spectrum
Published: January 29, 2025
The value of metagenomic next-generation sequencing with different nucleic acid extracting methods of cell-free DNA or whole-cell DNA in the diagnosis of non-neutropenic pulmonary aspergillosis.
Journal: Frontiers in cellular and infection microbiology
Published: March 09, 2024
Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy.
Journal: Frontiers in oncology
Published: June 07, 2023
The management and outcome of cryptococcosis in patients with different immune statuses and treatment protocols: A multicenter real-world study in Jiangsu Province - China.
Journal: Journal de mycologie medicale
Published: August 15, 2022
Clinical features of cryptococcosis in patients with different immune statuses: a multicenter study in Jiangsu Province-China.
Journal: BMC infectious diseases
Published: March 28, 2021
Advanced NSCLC Patients With EGFR T790M Harboring TP53 R273C or KRAS G12V Cannot Benefit From Osimertinib Based on a Clinical Multicentre Study by Tissue and Liquid Biopsy.
Journal: Frontiers in oncology
Published: October 27, 2020
Pulmonary metastasis of sclerosing sweat duct carcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: February 22, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026